Contraindications of Vivelle-Dot^®

Vivelle-Dot should not be used in women with any of the following conditions:

• Undiagnosed abnormal genital bleeding.
• Known, suspected or history of cancer of the breast.
• Known or suspected estrogen-dependent neoplasia.
• Active deep vein thrombosis, pulmonary embolism or a history of these conditions.
• Active or recent (e.g., within the past year) arterial thromboembolic disease (e.g., stroke, myocardial infarction).
• Liver dysfunction or disease.
• Vivelle-Dot should not be used in patients with known hypersensitivity to its ingredients.
• Known or suspected pregnancy. There is no indication for Vivelle-Dot in pregnancy. There appears to be little or no increased risk of birth defects in children born to women who have used estrogens and progestins from oral contraceptives inadvertently during early pregnancy.